Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 4:18 pm Sale | 2024-09-30 | 13G | Invivyd, Inc. IVVD | GV 2019 L.P. | 0 0.000% | -5,680,785 (Position Closed) | Filing History |
| 2024-02-29 4:15 pm Purchase | 2024-02-20 | 13G | Prime Medicine, Inc. PRME | GV 2019 L.P. | 15,062,498 12.200% | 3,200,000 (+26.98%) | Filing History |
| 2024-02-09 4:09 pm Sale | 2023-12-31 | 13G | Prime Medicine, Inc. PRME | GV 2019 L.P. | 11,862,498 12.200% | -1,422,190 (-10.71%) | Filing History |
| 2023-02-10 4:05 pm Purchase | 2022-12-31 | 13G | Prime Medicine, Inc. PRME | GV 2019 L.P. | 13,284,688 13.700% | 13,284,688 (New Position) | Filing History |
| 2022-02-14 12:36 pm Purchase | 2021-12-31 | 13G | EQRx, Inc. EQRX | GV 2019 L.P. | 47,252,687 9.690% | 47,252,687 (New Position) | Filing History |
| 2022-02-14 12:30 pm Purchase | 2021-12-31 | 13G | Invivyd, Inc. IVVD | GV 2019 L.P. | 5,680,785 5.110% | 5,680,785 (New Position) | Filing History |